Siyuan Cheng

1095 Jiefang Ave
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Molar Dose Optimization for Accurate Pharmacokinetic and Biodistribution Evaluation of FAP-Targeted Radiopharmaceuticals in a Mouse Syngeneic Tumor Model.

Molar Dose Optimization for Accurate Pharmacokinetic and Biodistribution Evaluation of FAP-Targeted Radiopharmaceuticals in a Mouse Syngeneic Tumor Model.

Journal: Molecular pharmaceutics
Published: January 05, 2026

Assessing outer retinal and choroidal changes in scd: potential for high-risk screening using SS-OCTA.

Assessing outer retinal and choroidal changes in scd: potential for high-risk screening using SS-OCTA.

Journal: Translational psychiatry
Published: May 15, 2025

Numerical Simulation Study on the Impact of Blind Zones in Ground Penetrating Radar.

Numerical Simulation Study on the Impact of Blind Zones in Ground Penetrating Radar.

Journal: Sensors (Basel, Switzerland)
Published: February 04, 2025

Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging.

Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging.

Journal: Molecular pharmaceutics
Published: December 10, 2024

Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings.

Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 07, 2024

Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.

Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.

Journal: European journal of nuclear medicine and molecular imaging
Published: September 26, 2024

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 04, 2023

Hepatic perivascular epithelioid cell tumor resembling hepatic adenoma and hepatocellular carcinoma on preoperative imaging: a case report.

Hepatic perivascular epithelioid cell tumor resembling hepatic adenoma and hepatocellular carcinoma on preoperative imaging: a case report.

Journal: Frontiers in oncology
Published: September 26, 2023

Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia.

Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia.

Journal: Nature communications
Published: January 31, 2023

Hepatic IDH2 regulates glycolysis and gluconeogenesis.

Hepatic IDH2 regulates glycolysis and gluconeogenesis.

Journal: Metabolism: clinical and experimental
Published: November 27, 2022

Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.

Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.

Journal: Clinical nuclear medicine
Published: February 10, 2022

Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.

Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.

Journal: Clinical nuclear medicine
Published: June 16, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026